Shanghai Rongtai Health Technology Corporation Limited

Symbol: 603579.SS




Market price today

  • 14.2953

    P/E Ratio

  • 0.1668

    PEG Ratio

  • 2.70B

    MRK Cap

  • 0.02%

    DIV Yield

Shanghai Rongtai Health Technology Corporation Limited (603579-SS) Stock Price & Analysis

Shares Outstanding


Gross Profit Margin


Operating Profit Margin


Net Profit Margin


Return on Assets


Return on Equity


Return on Capital Employed


Company general description and statistics

Sector: Consumer Cyclical
Industry: Leisure
CEO:Ms. Jinhua Liao
Full-time employees:1136
Address:NO.1226 Zhufeng Road

Shanghai Rongtai Health Technology Corporation Limited provides massage chairs, mini massage series products, and massage accessories in China and internationally. The company was founded in 1997 and is based in Shanghai, China.

General Outlook

When we look at how much money they make before expenses, they keep 0.322% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.140%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.122%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.066% return, is a testament to Shanghai Rongtai Health Technology Corporation Limited's adeptness in optimizing resource deployment. Shanghai Rongtai Health Technology Corporation Limited's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.115%. Furthermore, the proficiency of Shanghai Rongtai Health Technology Corporation Limited in capital utilization is underscored by a remarkable 0.094% return on capital employed.

Stock Prices

Shanghai Rongtai Health Technology Corporation Limited's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $19.99, while its low point bottomed out at $19.59. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Shanghai Rongtai Health Technology Corporation Limited's stock market.

Liquidity Ratios

Analyzing 603579.SS liquidity ratios reveals its financial health of the firm. The current ratio of 333.00% gauges short-term asset coverage for liabilities. The quick ratio (232.49%) assesses immediate liquidity, while the cash ratio (196.79%) indicates cash reserves.

Current Ratio333.00%
Quick Ratio232.49%
Cash Ratio196.79%

Profitability Ratios

603579.SS profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 13.68% underscores its earnings before tax deductions. The effective tax rate stands at 10.71%, revealing its tax efficiency. The net income per EBT, 89.08%, and the EBT per EBIT, 97.73%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 14.00%, we grasp its operational profitability.

Pretax Profit Margin13.68%
Effective Tax Rate10.71%
Net Income per EBT89.08%
EBT per EBIT97.73%
EBIT per Revenue14.00%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 3.33, it details the span from stock purchase to revenue. The 2 days it takes to settle debts showcases its creditor relations. Meanwhile, a 2 cash conversion cycle and 792.83% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

Days of Sales Outstanding232
Days of Inventory Outstanding54
Operating Cycle99.65
Days of Payables Outstanding93
Cash Conversion Cycle6
Receivables Turnover7.93
Payables Turnover3.91
Inventory Turnover6.81
Fixed Asset Turnover3.23
Asset Turnover0.54

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 1.29, and free cash flow per share, 0.63, depict cash generation on a per-share basis. The cash per share value, 9.82, showcases liquidity position. A payout ratio of 0.34 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, 0.09, offers insight into cash flow relative to sales.

Operating Cash Flow per Share1.29
Free Cash Flow per Share0.63
Cash per Share9.82
Payout Ratio0.34
Operating Cash Flow Sales Ratio0.09
Free Cash Flow to Operating Cash Flow Ratio0.48
Cash Flow Coverage Ratio0.20
Short Term Coverage Ratio0.72
Capital Expenditure Coverage Ratio1.94
Dividend Paid and Capex Coverage Ratio1.03
Dividend Payout Ratio0.03

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 25.29%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.43, we discern the balance between debt and equity financing. The long-term debt to capitalization, 23.58%, and total debt to capitalization, 29.88%, ratios shed light on its capital structure. An interest coverage of 13.58 indicates its ability to manage interest expenses.

Debt Ratio25.29%
Debt Equity Ratio0.43
Long Term Debt to Capitalization23.58%
Total Debt to Capitalization29.88%
Interest Coverage13.58
Cash Flow to Debt Ratio0.20
Company Equity Multiplier1.68

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 13.82, provides a glimpse into top-line earnings distributed across each share. Net income per share, 1.51, reflects the portion of profit attributed to each share. The book value per share, 14.67, represents the net asset value distributed per share, while the tangible book value per share, 13.91, excludes intangible assets.

Revenue Per Share13.82
Net Income Per Share1.51
Book Value Per Share14.67
Tangible Book Value Per Share13.91
Shareholders Equity Per Share14.67
Interest Debt Per Share5.83
Capex Per Share-0.67

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, -7.47%, indicates top-line expansion, while the gross profit growth, 7.53%, reveals profitability trends. EBIT growth, 26.49%, and operating income growth, 26.49%, offer insights into operational profitability progression. The net income growth, 23.43%, showcases bottom-line expansion, and the EPS growth, 24.79%, measures the growth in earnings per share.

Revenue Growth-7.47%
Gross Profit Growth7.53%
EBIT Growth26.49%
Operating Income Growth26.49%
Net Income Growth23.43%
EPS Growth24.79%
EPS Diluted Growth21.49%
Weighted Average Shares Growth-1.02%
Weighted Average Shares Diluted Growth1.67%
Dividends per Share Growth-23.87%
Operating Cash Flow Growth45.40%
Free Cash Flow Growth87.08%
10-Year Revenue Growth per Share233.63%
5-Year Revenue Growth per Share-15.73%
3-Year Revenue Growth per Share-6.74%
10-Year Operating CF Growth per Share231.88%
5-Year Operating CF Growth per Share37.39%
3-Year Operating CF Growth per Share26.91%
10-Year Net Income Growth per Share480.77%
5-Year Net Income Growth per Share-15.17%
3-Year Net Income Growth per Share6.69%
10-Year Shareholders Equity Growth per Share1042.84%
5-Year Shareholders Equity Growth per Share37.84%
3-Year Shareholders Equity Growth per Share20.53%
10-Year Dividend per Share Growth per Share65.50%
5-Year Dividend per Share Growth per Share-40.72%
3-Year Dividend per Share Growth per Share-61.68%
Receivables Growth38.88%
Inventory Growth-29.43%
Asset Growth-1.14%
Book Value per Share Growth6.59%
Debt Growth-25.34%
R&D Expense Growth-9.57%
SGA Expenses Growth-1.21%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 2,270,950,549.8, captures the company's total value, considering both debt and equity. Income quality, 1.69, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.01, gauges operational efficiency, while the research and development to revenue, 4.32%, highlights investment in innovation. The ratio of intangibles to total assets, 3.14%, indicates the value of non-physical assets, and capex to operating cash flow, -26.03%, measures reinvestment capability.

Enterprise Value2,270,950,549.8
Income Quality1.69
Sales General and Administrative to Revenue0.01
Research and Development to Revenue4.32%
Intangibles to Total Assets3.14%
Capex to Operating Cash Flow-26.03%
Capex to Revenue-4.83%
Capex to Depreciation-149.45%
Graham Number22.32
Return on Tangible Assets6.18%
Graham Net Net1.53
Working Capital1,561,065,418
Tangible Asset Value1,866,684,331
Net Current Asset Value815,771,751
Average Receivables167,710,902
Average Payables356,541,029.5
Average Inventory175,027,316.5
Days Sales Outstanding38
Days Payables Outstanding111
Days of Inventory On Hand41

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 1.59, and the price to book ratio, 1.59, reflect the market's valuation relative to the company's book value. The price to sales ratio, 1.76, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 39.35, and price to operating cash flows, 18.85, gauge market valuation against cash flow metrics.

Price Book Value Ratio1.59
Price to Book Ratio1.59
Price to Sales Ratio1.76
Price Cash Flow Ratio18.85
Price Earnings to Growth Ratio0.17
Enterprise Value Multiple13.64
Price Fair Value1.59
Price to Operating Cash Flow Ratio18.85
Price to Free Cash Flows Ratio39.35
Price to Tangible Book Ratio1.47
Enterprise Value to Sales1.22
Enterprise Value Over EBITDA7.10
EV to Operating Cash Flow6.60
Earnings Yield6.99%
Free Cash Flow Yield8.78%
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Shanghai Rongtai Health Technology Corporation Limited (603579.SS) on the SHH in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 14.295 in 2024.

What is the ticker symbol of Shanghai Rongtai Health Technology Corporation Limited stock?

The ticker symbol of Shanghai Rongtai Health Technology Corporation Limited stock is 603579.SS.

What is company IPO date?

IPO date of Shanghai Rongtai Health Technology Corporation Limited is 2017-01-11.

What is company current share price?

Current share price is 19.890 CNY.

What is stock market cap today?

The market cap of stock today is 2697591613.000.

What is PEG ratio in 2024?

The current 0.167 is 0.167 in 2024.

What is the number of employees in 2024?

In 2024 the company has 1136.